Ticker > Company >

Everest Organics share price

Everest Organics Ltd.

BSE: 524790 SECTOR: Pharmaceuticals & Drugs  24.47 K   169   10

410.00
-2.50 (-0.61%)
BSE: Today, 02:57 PM

Price Summary

Today's High

₹ 419.9

Today's Low

₹ 410

52 Week High

₹ 477

52 Week Low

₹ 112.5

FinStar

Ownership Stable
Ownership strength is slightly missing the benchmark.
ValuationExpensive
The stock is at a premium valuation at this point.
EfficiencyPoor
The company seems highly inefficient in case of asset management.
FinancialsWeak
Watch out! The company might not be able to sustain any adverse condition.
*It is just an analytical rating of the company and not an investment advice.

Company Essentials

Market Cap

398.13 Cr.

Enterprise Value

455.09 Cr.

No. of Shares

0.97 Cr.

P/E

64.24

P/B

5.58

Face Value

₹ 10

Div. Yield

0 %

Book Value (TTM)

₹  73.48

CASH

0.83 Cr.

DEBT

57.79 Cr.

Promoter Holding

60.99 %

EPS (TTM)

₹  6.38

Sales Growth

7.75%

ROE

0.3 %

ROCE

6.03%

Profit Growth

176.4 %

* Total debt includes long term borrowing, short term borrowing plus current maturities of long-term borrowing
* Ratios are based on latest Audited Financial Result.

Your Added Ratios

Please login to Add & View your own added ratios.

Login

Price Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

 

Volume Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

* Prices are based on daily market changes.
* The chart is based on the standalone earnings of the company. * Negative values and values more than 1000x in PE chart is considered 0.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

 Group Companies

Track the companies of Group.

Ratios

Sales Growth

1 Year7.75%
3 Year2.8%
5 Year4.82%

Profit Growth

1 Year176.4%
3 Year-78.35%
5 Year-54.96%

ROE%

1 Year0.3%
3 Year0.79%
5 Year14.51%

ROCE %

1 Year6.03%
3 Year5.33%
5 Year16.99%

Debt/Equity

1.2607

Price to Cash Flow

24.25

Interest Cover Ratio

1.1117

CFO/PAT (5 Yr. Avg.)

2.79314783356351

Shareholding Pattern

Promoter Pledging %

Date Promoter % Pledge %
Jun 2025 60.99 0.00
Mar 2025 61.09 0.00
Dec 2024 74.15 0.00
Sep 2024 74.15 0.00
Jun 2024 74.15 0.00
Investors List
* Figures given above are % of equity capital

 Strengths

  • Company’s PEG ratio is 0.36414556448556.
  • The company has an efficient Cash Conversion Cycle of -87.8255 days.
  • The company has a good cash flow management; CFO/PAT stands at 2.79314783356351.
  • The company has a high promoter holding of 60.99%.

 Limitations

  • The company has shown a poor profit growth of -78.3488414114868% for the Past 3 years.
  • The company has shown a poor revenue growth of 2.79853827395913% for the Past 3 years.
  • Company has a poor ROE of 0.786784147900473% over the past 3 years.
  • The company is trading at a high PE of 64.24.

Quarterly Result (All Figures in Cr.)

PARTICULARS Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025
Net Sales 32.45 44.05 42.05 40.94 53.81
Total Expenditure 36.1 40.62 38.03 37.5 49.38
Operating Profit -3.66 3.43 4.02 3.44 4.44
Other Income 0.33 0.14 0.01 0.22 0.55
Interest 1.29 1.35 1.4 1.15 1.31
Depreciation 1.47 1.47 1.47 1.56 1.52
Exceptional Items 0 0 0 0 0
Profit Before Tax -6.09 0.75 1.15 0.95 2.16
Tax 0 0.01 0.01 -1.96 0.76
Profit After Tax -6.09 0.74 1.14 2.91 1.41
Adjusted EPS (Rs) -7.61 0.93 1.43 3 1.45

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Net Sales 167.21 181.57 200.05 183.05 197.24
Total Expenditure 147.93 158.72 193.62 182.12 186.25
Operating Profit 19.28 22.84 6.43 0.93 10.99
Other Income 1.45 1.06 2.21 6.94 0.89
Interest 3.43 3.26 3.1 3.31 5.47
Depreciation 3.21 3.37 3.8 4.47 5.8
Exceptional Items 0 0 0 0 0
Profit Before Tax 14.09 17.27 1.74 0.09 0.61
Tax 3.2 3.56 0.6 0.27 0.47
Net Profit 10.9 13.72 1.14 -0.18 0.14
Adjusted EPS (Rs.) 13.62 17.14 1.43 -0.23 0.17

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Equity and Liabilities
Share Capital 8 8 8 8 8
Total Reserves 26.2 38.58 38.8 38.21 37.84
Borrowings 4.61 5.81 10.99 12.28 14.64
Other N/C liabilities 7.47 5.63 7.66 5.78 6.14
Current liabilities 74.01 77.36 112.56 137.58 160.1
Total Liabilities 120.29 135.38 178 201.85 226.72
Assets
Net Block 39.04 43.57 48.97 54.47 52.33
Capital WIP 1.13 0.08 8.03 9.49 19.35
Intangible WIP 0 0 0 2.1 1.68
Investments 0.08 0.08 0.08 0.08 0.08
Loans & Advances 0.91 2.4 3.04 3.23 3.3
Other N/C Assets 0 0 0 0 0
Current Assets 79.14 89.25 117.88 132.48 149.98
Total Assets 120.29 135.38 178 201.85 226.72
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Profit from operations 14.09 13.72 1.14 -0.18 0.14
Adjustment 3.51 6.38 6.72 7.75 10.65
Changes in Assets & Liabilities -7.89 -6.56 5.87 10.85 5.63
Tax Paid 0 0 0 0 0
Operating Cash Flow 9.71 13.53 13.74 18.42 16.42
Investing Cash Flow -6.31 -11.82 -16.82 -16.15 -13.32
Financing Cash Flow -3.36 -2.05 2.07 -2.64 -3.1
Net Cash Flow 0.04 -0.34 -1.01 -0.38 0

Corporate Actions

Investors Details

PARTICULARS Jun 2024% Sep 2024% Dec 2024% Mar 2025% Jun 2025%
promoters 74.15 74.15 74.15 61.09 60.99
bk advance research llp 2.80 2.80 2.80 2.30 2.30
hari krishna sk 0.07 0.07 0.07 0.06 0.06
kakarlapudi raju sitarama... 1.42 1.42 1.42 1.17 1.17
krishna veni srikakarlapu... - - - 3.25 16.01
nadimpalli v raju 1.41 1.41 1.41 1.16 1.16
rajagopal rao rangineni 0.70 0.70 0.70 0.58 0.58
s k sahitya - - - - 0.21
sri kakarlapudi sirisha 1.35 1.35 1.35 1.11 1.11
srikakarlapudi gowri parv... - - - - 0.02
veerat finance investment... - - 46.57 38.37 38.37
sk g parvathi 0.40 0.40 0.40 0.33 -
srihari raju srikakarlapu... - - 15.49 12.76 -
sri kakarlapudi krishna v... 3.94 3.94 3.94 - -
sri kakarlapudi sri hari ... 15.49 15.49 - - -
veerat finance & investme... 46.57 46.57 - - -
PARTICULARS Jun 2024% Sep 2024% Dec 2024% Mar 2025% Jun 2025%
investors 25.85 25.85 25.85 38.91 39.01
greenpath energy private ... - - - 8.47 8.47
llp - - - - 0.04
r venkata narayana - - - 7.79 7.79
sai prasanna manchineni - - - 1.02 1.02
everest organics limited ... 2.26 2.26 2.26 1.86 -

Annual Reports

Title Link
Title Link
Annual Report 2021
Annual Report 2020
Annual Report 2019
Annual Report 2018
Annual Report 2017
Annual Report 2017

Ratings & Research Reports

TYPE AGENCY Link
TYPE AGENCY Link
Credit BCRISP
Credit ICRA
Credit ICRA
TYPE AGENCY Link
TYPE AGENCY Link
 No Research reports exist for this company.Report us

Concalls & Presentations

TYPE QUARTER Link
TYPE QUARTER Link
 Currently we do not have any Concall related to this company.Report us
TYPE QUARTER Link
TYPE QUARTER Link
Presentation Q4FY20

Company News

Everest Organics informs about newspaper advertisements 6 Sep, 1:42 PM Everest Organics informs about press release 30 Aug, 12:04 PM Everest Organics informs about press release 8 Aug, 5:26 PM Everest Organics - Quaterly Results 5 Aug, 3:55 PM Everest Organics - Quaterly Results 5 Aug, 3:55 PM Everest Organics - Quaterly Results 5 Aug, 3:55 PM Everest Organics informs about trading window closure 27 Jun, 12:53 PM Everest Organics - Quaterly Results 28 May, 10:27 PM Everest Organics - Quaterly Results 28 May, 10:27 PM Everest Organics informs about change in corporate office 4 Apr, 2:57 PM Everest Organics informs about resignation of CS 27 Mar, 4:53 PM Everest Organics informs about disclosure 20 Mar, 3:11 PM Everest Organics informs about listing approval 12 Mar, 3:08 PM Everest Organics obtains KDMF approval for Rabeprazole Sodium API 18 Feb, 4:55 PM Everest Organics informs about press release 13 Feb, 4:45 PM Everest Organics - Quaterly Results 11 Feb, 6:18 PM Everest Organics - Quaterly Results 11 Feb, 6:18 PM Everest Organics informs about certificate 22 Jan, 12:27 PM Everest Organics informs about certificate 22 Jan, 10:00 AM Everest Organics informs about disclosure 15 Jan, 11:20 AM Everest Organics informs about newspaper publication 14 Jan, 5:11 PM Everest Organics informs about appointment of additional director 13 Jan, 3:02 PM Everest Organics informs about cancellation of board meeting 9 Dec, 5:21 PM Everest Organics informs about board meeting 7 Dec, 3:06 PM Everest Organics informs about resignation of independent director 4 Dec, 4:55 PM Everest Organics informs about retirement of non-executive director 4 Oct, 4:48 PM Everest Organics - Quaterly Results 13 Aug, 3:55 PM Everest Organics - Quaterly Results 13 Aug, 3:55 PM Everest Organics informs about board meeting 8 Aug, 9:49 AM Everest Organics - Quaterly Results 27 May, 7:07 PM Everest Organics - Quaterly Results 27 May, 7:07 PM Everest Organics - Quaterly Results 9 Feb, 3:33 PM Everest Organics - Quaterly Results 9 Feb, 3:33 PM Everest Organics - Quaterly Results 9 Feb, 3:33 PM Everest Organics informs about details of loss of certificate 25 Jan, 4:35 PM Everest Organics informs about press release 13 Nov, 1:52 PM Everest Organics informs about credit rating 24 Aug, 4:20 PM Everest Organics informs about press release 17 Aug, 12:39 PM Everest Organics informs about certificate 7 Jul, 5:40 PM Everest Organics informs about compliances-certificate 5 Apr, 4:51 PM Everest Organics - Quaterly Results 14 Feb, 3:19 PM Everest Organics informs about disclosure on related party transactions 18 Nov, 5:07 PM Everest Organics - Quaterly Results 11 Nov, 1:21 PM Everest Organics informs about board meeting 3 Nov, 4:17 PM Everest Organics informs about compliance certificate 6 Oct, 12:38 PM Everest Organics informs about annual report 2 Sep, 4:09 PM Everest Organics informs about AGM 2 Sep, 4:00 PM Everest Organics - Quaterly Results 9 Aug, 2:09 PM Everest Organics - Quaterly Results 9 Aug, 2:09 PM Everest Organics - Quaterly Results 9 Aug, 2:09 PM

Everest Organics Stock Price Analysis and Quick Research Report. Is Everest Organics an attractive stock to invest in?

Stock investing requires careful analysis of financial data to determine a company's true net worth. This is generally done by examining the company's profit and loss account, balance sheet and cash flow statement, which can be time-consuming and cumbersome.

Examining a company's financial ratios is an easier way to determine its performance, which can help to make sense of the overwhelming amount of information in its financial statements. 

Here are a few indispensable ratios that should be a part of every investor’s research process, or, in simpler words, how to analyse Everest Organics. 

  • PE ratio: Price to Earnings ratio, which indicates how much an investor is willing to pay for a share for every rupee of earnings. A general rule of thumb is that shares trading at a low P/E are undervalued (it depends on other factors too). Everest Organics has a PE ratio of 64.235131917027 which is high and comparatively overvalued.

  • Return on Assets (ROA): Return on Assets measures how effectively a company can earn a return on its investment in assets. In other words, ROA shows how efficiently a company can convert the money used to purchase assets into net income or profits. Everest Organics has ROA of 0.065% which is a bad sign for future performance. (Higher values are always desirable.)

  • Current ratio: The current ratio measures a company's ability to pay its short-term liabilities with its short-term assets. A higher current ratio is desirable so that the company could be stable to unexpected bumps in business and economy. Everest Organics has a Current ratio of 0.9368.

  • Return on equity: ROE measures the ability of a firm to generate profits from its shareholders' investments in the company. In other words, the return on equity ratio shows how much profit each rupee of common stockholders’ equity generates. Everest Organics has a ROE of 0.3024%. (Higher is better)

  • Debt to equity ratio: It is a good metric to check out the capital structure along with its performance. Everest Organics has a Debt to Equity ratio of 1.2607 which means that the company has low proportion of debt in its capital.

  • Sales growth: Everest Organics has reported revenue growth of 7.7536% which is poor in relation to its growth and performance. 

  • Operating Margin: This will tell you about the operational efficiency of the company. The operating margin of Everest Organics for the current financial year is 5.57013161036761%.

  • Dividend Yield: It tells us how much dividend we will receive in relation to the price of the stock. The current year dividend for Everest Organics is Rs 0 and the yield is 0%.

  • Earnings Per Share: It tells us how much profit is allocated to to each outstanding share of a common stock. The latest EPS of Everest Organics is Rs 6.3828. The higher the EPS, the better it is for investors. 

One can find all the Financial Ratios of Everest Organics in Ticker for free. Also, one can get the intrinsic value of Everest Organics by using Valuation Calculators, which are available with a Finology ONE subscription. 

Everest Organics FAQs

Q1. What is Everest Organics share price today?
Ans: The current share price of Everest Organics is Rs 410.

Q2. What is the market capitalisation of Everest Organics?
Ans: Everest Organics has a market capitalisation of Rs 398.131566 Cr., calculated based on its latest share price.

Q3. What are the P/E and P/B ratios of Everest Organics?
Ans: The PE ratio of Everest Organics is 64.235131917027 and the P/B ratio of Everest Organics is 5.57986349748566, showing how the stock is valued against its earnings and book value.

Q4. What is the 52-week high and low of Everest Organics share?
Ans: The 52-week high share price of Everest Organics is Rs 477, and the 52-week low share price of Everest Organics is Rs 112.5.

Q5. Does Everest Organics pay dividends?
Ans: Currently, Everest Organics does not pay dividends. Dividend yield of Everest Organics is around 0%.

Q6. What are the face value and book value of Everest Organics shares?
Ans: The face value of Everest Organics shares is Rs 10, while the book value per share of Everest Organics is around Rs 73.4785. Face value is the nominal value set by the company, whereas book value reflects its accounting worth.

Q7. What is the debt of Everest Organics?
Ans: Everest Organics has a total debt of Rs 57.7889 Cr., which affects investor sentiment and financial stability. 

Q8. What are the ROE and ROCE of Everest Organics?
Ans: The ROE of Everest Organics is 0.3024% and ROCE of Everest Organics is 6.0312%. ROE shows how efficiently the company is generating profit from shareholders’ equity, while the ROCE is reflects how efficiently the company uses its capital to generate returns.

Q9. Is Everest Organics a good buy for the long term?
Ans: The Everest Organics long-term outlook depends on debt levels, earnings growth, and sector trends. If it sustains profits and manages debt well, it may be considered for long-term investment.

Q10. Is Everest Organics undervalued or overvalued?
Ans: Based on valuation ratios like P/E, P/B, and EV/EBITDA, one can analyse whether the Everest Organics appears undervalued or overvalued at current levels. You can check detailed valuation metrics and peer comparisons on Finology Ticker.

Q11. How to check Everest Organics’s financials?
Ans: You can review Everest Organics’s financial statements - including balance sheet, income statement, and quarterly results - on Finology Ticker.

Last Updated on:
Brief about Everest Organics
X